Kenneth Aldape
Arzt
Hat mitgewirkt an:
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
-
Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care
-
High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
-
Germline findings in cancer predisposing genes from a small cohort of chordoma patients